Cullinan Oncology Inc.

25.44-0.8100-3.09%Vol 1.07M1Y Perf -14.54%
Jun 18th, 2021 16:00 DELAYED
BID25.30 ASK25.38
Open26.60 Previous Close26.25
Pre-Market- After-Market-
 - -  - -%
Target Price
51.75 
Analyst Rating
— — 0.00
Potential %
103.42 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap1.11B 
Earnings Rating
Price Range Ratio 52W %
1.83 
Earnings Date
13th Aug 2021

Today's Price Range

24.8026.60

52W Range

24.8059.85

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-18.96%
1 Month
-18.46%
3 Months
-38.12%
6 Months
-
1 Year
-14.54%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
CGEM25.44-0.8100-3.09
AAPL130.46-1.3300-1.01
GOOG2 511.35-16.0700-0.64
MSFT259.43-1.4700-0.56
XOM60.40-1.5900-2.56
WFC41.75-1.0400-2.43
JNJ161.98-3.2400-1.96
FB329.66-6.8500-2.04
GE12.78-0.2200-1.69
JPM147.92-3.8400-2.53
Earnings HistoryEstimateReportedSurprise %
Q01 20210.070.00-100.00
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date13th Aug 2021
Estimated EPS Next Report-0.41
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume1.07M
Shares Outstanding43.52M
Trades Count6.84K
Dollar Volume9.92M
Avg. Volume267.85K
Avg. Weekly Volume295.32K
Avg. Monthly Volume307.93K
Avg. Quarterly Volume271.86K

Cullinan Oncology Inc. (NASDAQ: CGEM) stock closed at 25.44 per share at the end of the most recent trading day (a -3.09% change compared to the prior day closing price) with a volume of 1.07M shares and market capitalization of 1.11B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 26 people. Cullinan Oncology Inc. CEO is Owen Hughes.

The one-year performance of Cullinan Oncology Inc. stock is -14.54%, while year-to-date (YTD) performance is %. CGEM stock has a five-year performance of %. Its 52-week range is between 24.8 and 59.85, which gives CGEM stock a 52-week price range ratio of 1.83%

Cullinan Oncology Inc. currently has a PE ratio of -28.20, a price-to-book (PB) ratio of 2.93, a price-to-sale (PS) ratio of 70.57, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -9.78%, a ROC of -10.16% and a ROE of -10.04%. The company’s profit margin is -%, its EBITDA margin is -281.70%, and its revenue ttm is $18.94 Million , which makes it $0.44 revenue per share.

Of the last four earnings reports from Cullinan Oncology Inc., there were 0 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.41 for the next earnings report. Cullinan Oncology Inc.’s next earnings report date is 13th Aug 2021.

The consensus rating of Wall Street analysts for Cullinan Oncology Inc. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Cullinan Oncology Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Cullinan Oncology Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Cullinan Oncology Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 27.10, ATR14 : 2.39, CCI20 : -152.88, Chaikin Money Flow : -0.29, MACD : -0.99, Money Flow Index : 40.11, ROC : -10.04, RSI : 35.17, STOCH (14,3) : 4.98, STOCH RSI : 0.00, UO : 33.51, Williams %R : -95.02), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Cullinan Oncology Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

Cullinan Oncology Inc.

Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.

CEO: Owen Hughes

Telephone: +1 617 410-4650

Address: One Main Street, Cambridge 02142, MA, US

Number of employees: 26

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

33%67%

News

Stocktwits